Quantification of huntingtin protein species in Huntington’s disease patient leukocytes using optimised electrochemiluminescence immunoassays

Hensman Moss, DJ; Robertson, N; Farmer, R; Scahill, RI; Haider, S; Tessari, MA; Flynn, G; Fischer, DF; Wild, EJ; Macdonald, D and Tabrizi, SJ (2017). Quantification of huntingtin protein species in Huntington’s disease patient leukocytes using optimised electrochemiluminescence immunoassays. [Dataset]. PLOS One. https://doi.org/10.1371/journal.pone.0189891
Copy

Huntington’s disease (HD) is an autosomal dominant neurodegenerative condition caused by an expanded CAG repeat in the gene encoding huntingtin (HTT). Optimizing peripheral quantification of huntingtin throughout the course of HD is valuable not only to illuminate the natural history and pathogenesis of disease, but also to detect peripheral effects of drugs in clinical trial.

Keywords

Huntington disease; Public and occupational health; Neuroimaging; Blood; Protein concentration assays; Electrochemistry; White blood cells; Immunoassays

No files available. Please consult associated links.


EndNote BibTeX Reference Manager Refer Atom Dublin Core (with Type as Type) JSON Multiline CSV Data Cite XML OpenURL ContextObject Simple Metadata MPEG-21 DIDL METS RDF+XML HTML Citation MODS OpenURL ContextObject in Span RDF+N-Triples OPENAIRE EP3 XML RDF+N3 ASCII Citation
Export